Aromatase inhibitors plus growth hormone may help short adolescent boys grow taller

April 4, 2016

Aromatase inhibitors, when used for up to three years in combination with growth hormone, may effectively and safely help very short adolescent boys grow taller, new research suggests. The study results will be presented Sunday, April 3, at ENDO 2016, the annual meeting of the Endocrine Society in Boston.

"Treating the growth-retarded child in puberty presents significant challenges not easily overcome by the use of (GH) alone, as the presence of sex steroids significantly limits the time available for linear growth in that period," said lead author Nelly Mauras, MD, chief of the Division of Endocrinology, Diabetes and Metabolism at Nemours Children's Health System in Jacksonville, Florida. "This work provides the longest treatment and follow up reported using (AIs) in adolescent males, showing an excellent safety profile. AIs may prolong the growth life of these children, allowing for taller height, without slowing down their progression through puberty."

During puberty, children grow rapidly and complete their linear growth at an average of around 14 1/2 years for girls and around 16 1/2 years for . Estrogen is mainly responsible for the fusion of growth plates in puberty (even in males, because some testosterone, the principal male hormone, is converted to estrogen). Aromatase inhibitors block the conversion of testosterone to estrogen.

Dr. Maurus and her colleagues compared the efficacy and safety of GH with AIs, alone and in combination (GH/AI), in 76 . The boys were, on average, 14.1 years of age and had idiopathic short stature (ISS), significant short stature without identifiable hormonal or other pathology. The groups were well-matched for height, , midparental height and bone age.

The researchers obtain the boys' body measurements, left-hand X-rays for bone ages, bone densitometry, lateral spine X-rays and blood samples at baseline. They randomly assigned 25 boys to receive injections of growth hormone (GH) alone, 25 to receive an oral AI (anastrozole or letrozole), and 26 to receive both, for 24 months. Those with residual height potential who wished to prolong their treatment were able to continue through 36 months.

At 24 months, the boys on combination GH/AI gained more height and had greater change in predicted adult height than those on GH or AIs alone, and those on GH/AI also accrued more lean body mass than the other groups.

The treatments were safe, with measures of bone health and adverse events comparable in all groups, and the patients continue to be monitored until they reach near-adult .

Explore further: Growth hormone treatment for children may exacerbate feelings of depression

Related Stories

Growth hormone treatment for children may exacerbate feelings of depression

June 23, 2014
Short, otherwise healthy children who are treated with growth hormone (GH) may become taller, but they may also become more depressed and withdrawn over time, compared to children the same age and height who are not treated ...

Short boys are 2 to 3 times as likely as short girls to receive growth hormone

June 10, 2015
Short boys are three times more likely than short girls to receive recombinant human growth hormone treatment for idiopathic short stature (ISS), even though in a general pediatric population, equal proportions of both genders ...

Drugs fail to meet hormone targets in control of rare growth disorder

October 10, 2013
Over a quarter of UK patients treated for growth hormone-producing tumours do not achieve 'safe' growth hormone (GH) levels, according to a 30 year UK multi-centre study of clinical management of the rare disease acromegaly. ...

ADHD medication can slow growth in teenage boys, study finds

January 21, 2013
(Medical Xpress)—Adolescent boys with attention deficit hyperactivity disorder (ADHD) are more likely to be shorter and slimmer than their same-age peers, according to a new study published in the Medical Journal of Australia ...

Should short boys take growth hormone?

March 27, 2013
(HealthDay)—Parents often worry when their child, especially a son, is much shorter than average. But as long as there is no medical cause, parents can rest easy, experts say.

Recommended for you

Study shows probiotics can prevent sepsis in infants

August 17, 2017
A research team at the University of Nebraska Medical Center College of Public Health has determined that a special mixture of good bacteria in the body reduced the incidence of sepsis in infants in India by 40 percent at ...

Children who sleep an hour less at higher risk of type 2 diabetes, says study

August 15, 2017
A study has found that children who slept on average one hour less a night had higher risk factors for type 2 diabetes, including higher levels of blood glucose and insulin resistance.

Low blood sugars in newborns linked to later difficulties

August 8, 2017
A newborn condition affecting one in six babies has been linked to impairment in some high-level brain functions that shows up by age 4.5 years.

Can breast milk feed a love of vegetables?

August 4, 2017
(HealthDay)—Want your preschooler to eat veggies without a fuss? Try eating veggies while you're breast-feeding.

Small drop in measles vaccinations would have outsized effect, study estimates

July 24, 2017
Small reductions in childhood measles vaccinations in the United States would produce disproportionately large increases in the number of measles cases and in related public health costs, according to a new study by researchers ...

At the cellular level, a child's loss of a father is associated with increased stress

July 18, 2017
The absence of a father—due to incarceration, death, separation or divorce—has adverse physical and behavioral consequences for a growing child. But little is known about the biological processes that underlie this link ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.